Volcon ePowersports Reports 2023 Operational and Financial Results
March 28, 2024 18:39 ET
|
Volcon, Inc.
Volcon ePowersports Reports 2023 Operational and Financial Results
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
March 28, 2024 16:15 ET
|
Unicycive Therapeutics, Inc.
– Oxylanthanum Carbonate (OLC) Topline Data Expected in Q2 2024 – – UNI-494 Granted Orphan Drug Designation in Delayed Graft Function of Acute Kidney Injury – – UNI-494 Phase 1 Single Ascending Dose...
Forian Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024 16:06 ET
|
Forian Inc.
Full Year 2023 Revenue Grew 25% Full Year 2023 Adjusted EBITDA of $2.3MM NEWTOWN, PA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq: FORA), a provider of...
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
March 28, 2024 16:05 ET
|
Assembly Biosciences, Inc.
Four candidates planned to be in clinical development in 2024 with interim data from two studies anticipated by year end Clinical development timelines accelerated for ABI-5366; now anticipating...
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
March 28, 2024 16:01 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company committed to the global development and...
Lowell Farms Inc. Announces Audited Fourth Quarter and Fiscal Year 2023 Financial and Operational Results
March 28, 2024 08:00 ET
|
Lowell Farms Inc.
SALINAS, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis company with advanced distribution and production capabilities...
HEALWELL AI Reports Q4 and Full Year 2023 Financial Results
March 28, 2024 07:45 ET
|
HEALWELL AI Inc.
HEALWELL AI Reports Q4 and Full Year 2023 Financial Results
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
March 28, 2024 07:35 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for...
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
March 28, 2024 07:00 ET
|
atai Life Sciences
Strategic investment in Beckley Psytech to accelerate the development of psychedelic-based therapies that fit within the two hour in-clinic treatment paradigm established by Spravato®Initial BPL-003...
Vast Renewables Limited Announces Operational and Financial Results for First Half of Fiscal 2024
March 28, 2024 01:15 ET
|
Vast Renewables Limited
Operational and Funding Highlights Investment of €10.0 million from EDF Australia, a subsidiary of EDF GroupEquity investment from the Canberra Airport Group valued at USD $9.2 millionSubsequently...